RBCL Stock Overview
Manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
RBC Life Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000067 |
| 52 Week High | US$0.0003 |
| 52 Week Low | US$0.000067 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -66.50% |
| 33 Year Change | -99.95% |
| 5 Year Change | -99.89% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| RBCL | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | -0.9% | 1.2% |
| 1Y | -66.5% | -15.9% | 30.2% |
Return vs Industry: RBCL underperformed the US Personal Products industry which returned -28.8% over the past year.
Return vs Market: RBCL underperformed the US Market which returned 22% over the past year.
Price Volatility
| RBCL volatility | |
|---|---|
| RBCL Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.2% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RBCL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RBCL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | David Price | www.rbclifesciences.com |
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company’s Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity.
RBC Life Sciences, Inc. Fundamentals Summary
| RBCL fundamental statistics | |
|---|---|
| Market cap | US$2.83k |
| Earnings (TTM) | -US$559.51k |
| Revenue (TTM) | US$24.12m |
0.0x
P/S Ratio0.0x
P/E RatioIs RBCL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RBCL income statement (TTM) | |
|---|---|
| Revenue | US$24.12m |
| Cost of Revenue | US$10.39m |
| Gross Profit | US$13.72m |
| Other Expenses | US$14.28m |
| Earnings | -US$559.51k |
Last Reported Earnings
Sep 30, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did RBCL perform over the long term?
See historical performance and comparison